GAC

1.

Global Fund Board approves initiatives worth $18 million from the Unfunded Quality Demand Register

31 Jul 2019
A private sector contribution of $2 million will support RAI grant in Southeast Asia; others through portfolio optimization

On 24 July 2019, the Global Fund Board approved funding in the amount of $18.0 million from the 2017-2019 allocations for several interventions on the Unfunded Quality Demand (UQD) Register. The funds will be added to three existing country grants and one existing multi-country grant. The sources of these funds are portfolio optimization and a private sector contribution. (See Table 1 below.)

2.

Global Fund invests $40 million to facilitate $400-million World Bank loan to India

26 Jun 2019
Loan ‘buy-down’ leverages increased resources to frontload India’s investment, help achieve impact quickly

The Global Fund describes the $41.6 million in funding awarded to India in April as an innovative approach that will catalyze significant additional funding for the fight against tuberculosis. The award includes $40.0 million to buy down a portion of a $400.0-million loan from the World Bank over five years.

1.

Global Fund Board approves new country and multi-country grants along with interventions on UQD Register

27 May 2019
Largest single award was $13.2 million for a Burkina Faso malaria grant

On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)

5.

New implementation arrangements for the Global Fund’s TB grants to Nigeria

28 Jan 2019
Transition to the new arrangements will happen in the first six months of 2019

New implementation arrangements have been put in place for the TB programs funded through Nigeria’s new TB and TB/HIV grants.

6.

The Global Fund seeks the right balance between risk mitigation and grant implementation in Mali malaria grant

28 Jan 2019
Because of Mali’s extreme malaria burden, its grant portfolio has been designated “high impact”

When it recommended a Mali malaria grant for approval recently, the Global Fund’s Grant Approvals Committee (GAC) acknowledged that there are implementation challenges associated with this grant and said that it welcomed the Secretariat’s plans “to identify bottlenecks, and holistically review and harmonize the controls in place with the aim of balancing risk mitigation and effective grant implementation.”

7.

Three multi-country initiatives were among grants approved by the Global Fund Board

28 Jan 2019
Two grants in the EECA and one in West and Central Africa were valued collectively at $24 million

Among the grants approved by the Global Fund Board on 21 December 2018 (see GFO article) were three multi-country grants. Two of the grants were for Eastern Europe and Central Asia (EECA); the third was for West and Central Africa. (See table.)

9.

Of the $98 million in country grants approved by Global Fund Board from 2017-2019 allocations, Latin America and Caribbean receive $57 million

11 Dec 2018
Domestic commitments for the nine grants in the region amount to $399 million

This is the second of two articles in this issue on the grants recently approved by the Global Fund Board. In this article, we report on the comments of the Grant Approvals Committee (GAC) on four countries in the Latin American and Caribbean region: Belize, El Salvador, Panama and Paraguay.

1.

Global Fund Board approves another $98 million in country grants from the 2017–2019 allocations

7 Dec 2018
$13 million for multi-country grants also approved
Montenegro one of first transition countries to allocate government financing to key populations

On 12 November 2018,  through electronic voting, the Global Fund Board approved $98.0 million in funding for 14 country grants from 13 countries. Of the 14 grants, four were for TB; three TB/HIV; three HIV; three malaria; and one TB/RSSH.

6.

Global Fund Board approves funding for first set of interventions on UQD register for 2017–2019 identified through portfolio optimization

5 Nov 2018
$15 million approved for grants in Burundi and Philippines; more to come
3.

Global Fund Board approves another $28 million in grants from the 2017–2019 allocations

5 Nov 2018
$16 million in matching funds also approved
Countries include Armenia, Bhutan, Chad, Comoros, Côte d’Ivoire, Djibouti, El Salvador, Guatemala, Lesotho, Madagascar, Mozambique, Romania, Suriname, Tunisia

On 17 August 2018 and on 26 October 2018, the Global Fund Board approved two HIV grants and three TB grants worth $28.1 million. The Board also approved $15.9 million in matching funds requests for six components.

Страницы

Подписка на GAC